Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis
Int. Journal of Clinical Pharmacology and Therapeutics · 2025
DOI: 10.5414/cp204706 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Xuechun Gu und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alendronate, Bone Density, Bone Density Conservation Agents, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Gu, X., Zhang, L., Chen, X., & Kong, L. (2025). Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204706
Vancouver
Gu X, Zhang L, Chen X, Kong L. Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204706
BibTeX
@article{Gu2025,
author = {Gu, Xuechun and Zhang, Liyuan and Chen, Xiangyi and Kong, Lingyan},
title = {Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2025},
doi = {10.5414/cp204706}
}
EUVIMED